Avadel Pharmaceuticals plc logo
Avadel Pharmaceuticals plc AVDL
$ 11.42 6.23%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Avadel Pharmaceuticals plc Balance Sheet 2011-2024 | AVDL

Annual Balance Sheet Avadel Pharmaceuticals plc

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

-28.5 M -72.2 M 92.6 M 56.6 M 166 M 107 M -16.3 M -38.4 M -63.9 M 78.7 M 78.9 M 33.9 M 259 K

Long Term Debt

1.69 M 780 K 142 M 128 M 122 M 116 M 156 K 547 K 684 K 76.1 M 66.3 M 33.3 M 1.69 M

Long Term Debt Current

934 K 960 K 900 K 474 K 645 K 106 K 111 K 268 K 434 K 42.3 M 19.2 M 3.35 M 2.03 M

Total Non Current Liabilities

- - - 134 M 145 M 149 M 81.2 M 141 M 98.3 M 78.5 M 85.2 M 72.4 M 21.3 M

Total Current Liabilities

36.9 M 55.8 M 21 M 15.1 M 36 M 38.4 M 86.5 M 62.4 M 48.8 M 70.7 M 39.7 M 14.4 M 18.3 M

Total Liabilities

77 M 154 M 169 M 149 M 181 M 188 M 168 M 203 M 147 M 149 M 126 M 86.8 M 39.6 M

Deferred Revenue

- - - - - 114 K 2.01 M 2.22 M 5.12 M 1.34 M 1.38 M 1.19 M 4.8 M

Retained Earnings

-745 M -585 M -448 M -384 M -391 M -358 M -263 M -320 M -280 M -320 M -236 M -193 M -189 M

Total Assets

165 M 133 M 247 M 312 M 151 M 190 M 253 M 245 M 215 M 174 M 116 M 117 M 69.4 M

Cash and Cash Equivalents

31.2 M 74 M 50.7 M 71.7 M 9.77 M 9.32 M 16.6 M 39.2 M 65.1 M 39.8 M 6.64 M 2.74 M 3.46 M

Book Value

87.7 M -21.1 M 78.2 M 162 M -29.2 M 2.78 M 85.6 M 42.1 M 67.9 M 24.9 M -9.51 M 30.5 M 29.8 M

Total Shareholders Equity

87.7 M -21.1 M 78.2 M 162 M -29.2 M 2.78 M 85.6 M 42.1 M 69.1 M 25 M -9.51 M 30.5 M 29.8 M

All numbers in USD currency

Quarterly Balance Sheet Avadel Pharmaceuticals plc

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

1.22 M 1.31 M 1.45 M 1.69 M 1.93 M - 93.1 M 780 K 110 M 108 M 117 M 142 M 142 M 142 M 141 M 128 M 128 M 128 M 128 M 122 M 122 M 122 M 122 M 116 M 116 M 116 M 116 M 156 K 156 K 156 K 156 K 547 K 547 K 547 K 547 K 684 K 684 K 684 K 684 K 1.28 M 68 M 69.4 M 56.6 M 66.3 M 65.4 M 78 M - 33.3 M - 47.8 M 47.8 M 1.69 M - - -

Total Non Current Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 120 M 86.5 M 78.5 M 76.6 M 78.9 M 66.3 M 77.5 M 98.3 M 111 M - 72.4 M - 92.1 M 88.2 M 21.3 M - - -

Total Liabilities

83.6 M 87.2 M 89.5 M 77 M 93 M 57.8 M 179 M 154 M 158 M 161 M 166 M 169 M 165 M 164 M 156 M 149 M 149 M 149 M 149 M 181 M 181 M 181 M 181 M 188 M 188 M 188 M 188 M 168 M 168 M 168 M 168 M 203 M 203 M 203 M 203 M 146 M 146 M 146 M 147 M 149 M - - - 698 K - - - - - - - - - - -

Deferred Revenue

- - - - - - - - - - - - - - - - - - - - - - - 114 K - - - 2.01 M 1.93 M 2.46 M 1.62 M 2.22 M 2.22 M 2.22 M 2.22 M 5.12 M 5.12 M 5.12 M 5.12 M 1.34 M 612 K 954 K 157 K 1.26 M 1 M 190 K - 614 K - 2.49 M 2.98 M 2.84 M - - -

Retained Earnings

-789 M -787 M -773 M -745 M -717 M -680 M -616 M -585 M -558 M -538 M -474 M -448 M -425 M -403 M -384 M -384 M -384 M -384 M -384 M -391 M -391 M -391 M -391 M -358 M -358 M -358 M -358 M -263 M -263 M -263 M -263 M -320 M -320 M -320 M -320 M -279 M -279 M -279 M -280 M -320 M -293 M -283 M -262 M -236 M -241 M -234 M - -193 M - -195 M -189 M -189 M - - -

Total Assets

158 M 158 M 168 M 165 M 203 M 201 M 141 M 133 M 146 M 158 M 221 M 247 M 264 M 283 M 293 M 312 M 312 M 312 M 312 M 151 M 151 M 151 M 151 M 190 M 190 M 190 M 190 M 253 M 253 M 253 M 253 M 245 M 245 M 245 M 245 M 215 M 215 M 215 M 215 M 174 M 164 M 175 M 182 M 116 M 117 M 118 M - 117 M - 134 M 137 M 69.4 M - - -

Cash and Cash Equivalents

28.6 M 28.8 M 35.8 M 31.2 M 51.8 M 50 M 83.4 M 74 M 60.7 M 54.1 M 60.9 M 50.7 M 58.2 M 67.1 M 59.2 M 71.7 M 71.7 M 71.7 M 71.7 M 9.77 M 9.77 M 9.77 M 9.77 M 9.32 M 9.32 M 9.32 M 9.32 M 16.6 M 16.6 M 16.6 M 16.6 M 39.2 M 39.2 M 39.2 M 39.2 M 65.1 M 65.1 M 65.1 M 65.1 M 39.8 M 24 M 54.1 M 55.5 M 6.64 M 7.8 M 8.34 M 14 M 2.74 M 3.12 M 4.76 M 4.35 M 3.46 M - 11.6 M 5.83 M

Book Value

74.7 M 70.3 M 78.4 M 87.7 M 110 M 143 M -38.2 M -21.1 M -12.4 M -3.33 M 55.2 M 78.2 M 99 M 119 M 137 M 162 M 162 M 162 M 162 M -29.2 M -29.2 M -29.2 M -29.2 M 2.78 M 2.78 M 2.78 M 2.78 M 85.6 M 85.6 M 85.6 M 85.6 M 42.1 M 42.1 M 42.1 M 42.1 M 69.1 M 69.1 M 69.1 M 67.9 M 24.9 M 164 M 175 M 182 M 116 M 117 M 118 M - 117 M - 134 M 137 M 69.4 M - - -

Total Shareholders Equity

74.7 M 70.3 M 78.4 M 87.7 M 110 M 143 M -38.2 M -21.1 M -12.4 M -3.33 M 55.2 M 78.2 M 99 M 119 M 137 M 162 M 162 M 162 M 162 M -29.2 M -29.2 M -29.2 M -29.2 M 2.78 M 2.78 M 2.78 M 2.78 M 85.6 M 85.6 M 85.6 M 85.6 M 42.1 M 42.1 M 42.1 M 42.1 M 69.1 M 69.1 M 69.1 M 67.9 M 25 M 40 M 57.9 M 78.1 M -8.82 M -15.4 M -10.1 M - 30.5 M - 25.4 M 32 M 29.8 M - - -

All numbers in USD currency